Long Term Subcutaneous Tinzaparin [tinzaparin sodium] Compared With Tinzaparin and Oral Anticoagulants [acenocoumarol] in the Treatment of the Acute Pulmonary Embolism.

Trial Profile

Long Term Subcutaneous Tinzaparin [tinzaparin sodium] Compared With Tinzaparin and Oral Anticoagulants [acenocoumarol] in the Treatment of the Acute Pulmonary Embolism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Acenocoumarol; Tinzaparin sodium
  • Indications Pulmonary embolism
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Feb 2009 Actual patient numbers (102) added as reported by ClinicalTrials.gov.
    • 12 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top